0
Skip to Content
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Home
Agenda
Venue & Accommodation
Folder: Previous years
Back
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW

Targeting ion channels

Session 2: New targets: Neuropeptides and ion channels

Messoud Ashina

Professor of Neurology, University of Copenhagen, Rigshospitalet-Glostrup, Denmark

Download presentation

Previous

PACAP and VIP

Next

Safety and tolerability, wearing-off

You Might Also Like

Related Embedded Video Item Thumbnail Clinical Implications
Related Embedded Video Item Thumbnail The Headache Calculator - A diagnostic tool
Related Embedded Video Item Thumbnail Discrepancy between the recommendations and reimbursement regulations of the anti-CGRPs in the Nordics
Related Embedded Video Item Thumbnail Epidemiological and clinical aspects
Related Embedded Video Item Thumbnail Pathophysiological Aspects

Privacy policy

Teva Privacy Notice |Teva Pharmaceuticals

Legal Notes | Teva Pharmaceuticals

Accessibility Statement

Teva code of conduct


Norway, Finland, Denmark: AJO-DK-NP-00128